InMed Pharmaceuticals Inc. (INM)
NasdaqCM - NasdaqCM 延遲價格。貨幣為 USD。
加入追蹤清單
收市：04:00PM EDT
收市後：
| 前收市價 | 0.3053 |
| 開市 | 0.2861 |
| 買盤 | 0.2861 x 100 |
| 賣出價 | 0.2899 x 100 |
| 今日波幅 | 0.2836 - 0.3000 |
| 52 週波幅 | 0.2280 - 2.0800 |
| 成交量 | |
| 平均成交量 | 504,347 |
| 市值 | 2.423M |
| Beta 值 (5 年，每月) | 無 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -0.5400 |
| 業績公佈日 | 2024年5月14日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 無 |
BenzingaWhy Are InMed Pharmaceuticals Stock Trading Lower Today
InMed Pharmaceuticals Inc (NASDAQ: INM) shares are trading lower after the company released safety and efficacy results from its Phase 2 clinical trial (755-201-EB) for symptoms related to Epidermolysis Bullosa (EB). The Phase 2 Trial enrolled 19 patients, with data from one patient excluded from efficacy analysis due to protocol deviation. Chronic itch improved in 12 patients (66.7%), with some patients showing the same level of improvement with INM-755cannabinol (CBN) cream as with the control
